Marijuana Research - Benefits, Cancer, Effects, Uses, Addiction

Marijuana Research Today is a free monthly online journal that collates and summarizes the latest research about Marijuana, including details on benefits, cancer, effects, uses, addiction.


Marijuana Research Today

Home

View Latest Issue

Information About Marijuana

Books on Marijuana

Advertising in Research Today

View Other Research Today Publications

Volume 8 (2011), Issue 1 (January)

  1. Joint Modeling of Longitudinal Data in Multiple Behavioral Change.
    Eval Health Prof. [Abstract] [Full-text]
  2. Failure to sustain prepulse inhibition in adolescent marijuana users.
    Drug Alcohol Depend. [Abstract] [Full-text]
  3. A dual process account of adolescent and adult binge drinking.
    Addict Behav. [Abstract] [Full-text]
  4. Social Networking Technology, Social Network Composition, and Reductions in Substance Use Among Homeless Adolescents.
    Prev Sci. [Abstract] [Full-text]
  5. Why do patients with psychosis use cannabis and are they ready to change their use?
    Int J Dev Neurosci. [Abstract] [Full-text]
  6. Cannabidiol decreases body weight gain in rats: Involvement of CB2 receptors.
    Neurosci Lett. [Abstract] [Full-text]
  7. Creating REAL MEN: Description of an Intervention to Reduce Drug Use, HIV Risk, and Rearrest Among Young Men Returning to Urban Communities From Jail.
    Health Promot Pract, 12(1): 44-54. [Abstract] [Full-text]
  8. Joint Modeling of Longitudinal Data in Multiple Behavioral Change.
    Eval Health Prof. [Abstract] [Full-text]
  9. Failure to sustain prepulse inhibition in adolescent marijuana users.
    Drug Alcohol Depend. [Abstract] [Full-text]
  10. A dual process account of adolescent and adult binge drinking.
    Addict Behav. [Abstract] [Full-text]
  11. Social Networking Technology, Social Network Composition, and Reductions in Substance Use Among Homeless Adolescents.
    Prev Sci. [Abstract] [Full-text]
  12. Why do patients with psychosis use cannabis and are they ready to change their use?
    Int J Dev Neurosci. [Abstract] [Full-text]
  13. Creating REAL MEN: description of an intervention to reduce drug use, HIV risk, and rearrest among young men returning to urban communities from jail.
    Health Promot Pract, 12(1): 44-54. [Abstract] [Full-text]
  14. Joint Modeling of Longitudinal Data in Multiple Behavioral Change.
    Eval Health Prof. [Abstract] [Full-text]
  15. Failure to sustain prepulse inhibition in adolescent marijuana users.
    Drug Alcohol Depend. [Abstract] [Full-text]
  16. Social Networking Technology, Social Network Composition, and Reductions in Substance Use Among Homeless Adolescents.
    Prev Sci. [Abstract] [Full-text]
  17. Effects of cannabinoid CB(1) receptor agonism and antagonism on SKF81297-induced dyskinesia and haloperidol-induced dystonia in Cebus apella monkeys.
    Neuropharmacology, 60(2): 418-22. [Abstract] [Full-text]
  18. Exposure to a high-fat diet decreases sensitivity to Δ(9)-tetrahydrocannabinol-induced motor effects in female rats.
    Neuropharmacology, 60(2): 274-83. [Abstract] [Full-text]
  19. Creating REAL MEN: description of an intervention to reduce drug use, HIV risk, and rearrest among young men returning to urban communities from jail.
    Health Promot Pract, 12(1): 44-54. [Abstract] [Full-text]
  20. Effects of cannabinoid CB(1) receptor agonism and antagonism on SKF81297-induced dyskinesia and haloperidol-induced dystonia in Cebus apella monkeys.
    Neuropharmacology, 60(2): 418-22. [Abstract] [Full-text]
  21. Exposure to a high-fat diet decreases sensitivity to Δ(9)-tetrahydrocannabinol-induced motor effects in female rats.
    Neuropharmacology, 60(2): 274-83. [Abstract] [Full-text]
  22. Effects of cannabinoid CB(1) receptor agonism and antagonism on SKF81297-induced dyskinesia and haloperidol-induced dystonia in Cebus apella monkeys.
    Neuropharmacology, 60(2): 418-22. [Abstract] [Full-text]
  23. Exposure to a high-fat diet decreases sensitivity to Δ(9)-tetrahydrocannabinol-induced motor effects in female rats.
    Neuropharmacology, 60(2): 274-83. [Abstract] [Full-text]
  24. Pharmacological Treatment of Painful HIV-Associated Sensory Neuropathy: A Systematic Review and Meta-Analysis of Randomised Controlled Trials.
    PLoS One, 5(12): e14433. [Abstract] [Full-text]
  25. Developmental trajectories of marijuana use from adolescence to adulthood: personal predictors.
    Arch Pediatr Adolesc Med, 165(1): 55-60. [Abstract] [Full-text]
  26. Dysfunctional Brain Networks and Genetic Risk for Schizophrenia: Specific Neurotransmitter Systems.
    CNS Neurosci Ther. [Abstract] [Full-text]
  27. Association between cannabis and psychiatric hospitalization.
    Acta Psychiatr Scand. [Abstract] [Full-text]
  28. Pharmacological treatment of painful HIV-associated sensory neuropathy: a systematic review and meta-analysis of randomised controlled trials.
    PLoS One, 5(12): e14433. [Abstract] [Full-text]
  29. Developmental trajectories of marijuana use from adolescence to adulthood: personal predictors.
    Arch Pediatr Adolesc Med, 165(1): 55-60. [Abstract] [Full-text]
  30. Dysfunctional Brain Networks and Genetic Risk for Schizophrenia: Specific Neurotransmitter Systems.
    CNS Neurosci Ther. [Abstract] [Full-text]
  31. Association between cannabis and psychiatric hospitalization.
    Acta Psychiatr Scand. [Abstract] [Full-text]
  32. Pharmacological treatment of painful HIV-associated sensory neuropathy: a systematic review and meta-analysis of randomised controlled trials.
    PLoS One, 5(12): e14433. [Abstract] [Full-text]
  33. Developmental trajectories of marijuana use from adolescence to adulthood: personal predictors.
    Arch Pediatr Adolesc Med, 165(1): 55-60. [Abstract] [Full-text]
  34. Dysfunctional Brain Networks and Genetic Risk for Schizophrenia: Specific Neurotransmitter Systems.
    CNS Neurosci Ther. [Abstract] [Full-text]
  35. Association between cannabis and psychiatric hospitalization.
    Acta Psychiatr Scand. [Abstract] [Full-text]
  36. Drug abuse in plastic surgery patients: optimizing detection and minimizing complications.
    Plast Reconstr Surg, 127(1): 445-55. [Abstract] [Full-text]
  37. Trajectories of marijuana use and psychological adjustment among urban African American and Puerto Rican women.
    Psychol Med. [Abstract] [Full-text]
  38. The validity of DSM-IV cannabis abuse and dependence criteria in adolescents and the value of additional cannabis use indicators.
    Addiction. [Abstract] [Full-text]
  39. Cannabis-related hospitalisations: unexpected serious events identified through hospital databases.
    Br J Clin Pharmacol. [Abstract] [Full-text]
  40. The validity of DSM-IV cannabis abuse and dependence criteria in adolescents and the value of additional cannabis use indicators.
    Addiction. [Abstract] [Full-text]
  41. Cannabis-related hospitalisations: unexpected serious events identified through hospital databases.
    Br J Clin Pharmacol. [Abstract] [Full-text]
  42. Cannabis use and development of externalizing and internalizing behaviour problems in early adolescence: A TRAILS study.
    Drug Alcohol Depend. [Abstract] [Full-text]
  43. Cannabis use and development of externalizing and internalizing behaviour problems in early adolescence: A TRAILS study.
    Drug Alcohol Depend. [Abstract] [Full-text]
  44. The 'grass ceiling': limitations in the literature hinder our understanding of cannabis use and its consequences.
    Addiction, 106(2): 238-44. [Abstract] [Full-text]
  45. The 'grass ceiling': limitations in the literature hinder our understanding of cannabis use and its consequences.
    Addiction, 106(2): 238-44. [Abstract] [Full-text]
  46. The 'grass ceiling': limitations in the literature hinder our understanding of cannabis use and its consequences.
    Addiction, 106(2): 238-44. [Abstract] [Full-text]
  47. Cannabidiol exerts anti-convulsant effects in animal models of temporal lobe and partial seizures.
    Seizure. [Abstract] [Full-text]
  48. Cannabidiol exerts anti-convulsant effects in animal models of temporal lobe and partial seizures.
    Seizure. [Abstract] [Full-text]
  49. Cannabidiol exerts anti-convulsant effects in animal models of temporal lobe and partial seizures.
    Seizure. [Abstract] [Full-text]
  50. High Prevalence of Echocardiographic Abnormalities among HIV-infected Persons in the Era of Highly Active Antiretroviral Therapy.
    Clin Infect Dis, 52(3): 378-386. [Abstract] [Full-text]
  51. Expectancies and self-efficacy mediate the effects of impulsivity on marijuana use outcomes: An application of the acquired preparedness model.
    Addict Behav. [Abstract] [Full-text]
  52. Drinking and driving among immigrant and US-born Hispanic young adults: Results from a longitudinal and nationally representative study.
    Addict Behav. [Abstract] [Full-text]
  53. High Prevalence of Echocardiographic Abnormalities among HIV-infected Persons in the Era of Highly Active Antiretroviral Therapy.
    Clin Infect Dis, 52(3): 378-86. [Abstract] [Full-text]
  54. Review: The neuropathology of drug abuse.
    Neuropathol Appl Neurobiol, 37(2): 118-34. [Abstract] [Full-text]
  55. LC-MS-MS method for simultaneous determination of THCCOOH and THCCOOH-glucuronide in urine: Application to workplace confirmation tests.
    Forensic Sci Int, 204(1): 67-73. [Abstract] [Full-text]
  56. High Prevalence of Echocardiographic Abnormalities among HIV-infected Persons in the Era of Highly Active Antiretroviral Therapy.
    Clin Infect Dis, 52(3): 378-86. [Abstract] [Full-text]
  57. Review: The neuropathology of drug abuse.
    Neuropathol Appl Neurobiol, 37(2): 118-34. [Abstract] [Full-text]
  58. LC-MS-MS method for simultaneous determination of THCCOOH and THCCOOH-glucuronide in urine: Application to workplace confirmation tests.
    Forensic Sci Int, 204(1): 67-73. [Abstract] [Full-text]
  59. High Prevalence of Echocardiographic Abnormalities among HIV-infected Persons in the Era of Highly Active Antiretroviral Therapy.
    Clin Infect Dis, 52(3): 378-86. [Abstract] [Full-text]
  60. Review: The neuropathology of drug abuse.
    Neuropathol Appl Neurobiol, 37(2): 118-34. [Abstract] [Full-text]
  61. LC-MS-MS method for simultaneous determination of THCCOOH and THCCOOH-glucuronide in urine: Application to workplace confirmation tests.
    Forensic Sci Int, 204(1): 67-73. [Abstract] [Full-text]
  62. A Combined Preclinical Therapy of Cannabinoids and Temozolomide against Glioma.
    Mol Cancer Ther, 10(1): 90-103. [Abstract] [Full-text]
  63. Alcohol, cannabis and amphetamine-type stimulants use among young Pacific Islanders.
    Drug Alcohol Rev, 30(1): 104-10. [Abstract] [Full-text]
  64. Recreational substance use among elite Australian athletes.
    Drug Alcohol Rev, 30(1): 63-8. [Abstract] [Full-text]
  65. Detecting psychological symptoms related to substance use among Indigenous Australians.
    Drug Alcohol Rev, 30(1): 33-9. [Abstract] [Full-text]
  66. Reported value of cannabis seizures in Australian newspapers: Are they accurate?
    Drug Alcohol Rev, 30(1): 21-5. [Abstract] [Full-text]
  67. Prevalence and intensity of basic symptoms among cannabis users: an observational study.
    Am J Drug Alcohol Abuse. [Abstract] [Full-text]
  68. Race and Sexually Transmitted Diseases in Women With and Without Borderline Personality Disorder.
    J Womens Health (Larchmt). [Abstract] [Full-text]
  69. Changes in self-control problems and attention problems during middle school predict alcohol, tobacco, and marijuana use during high school.
    Psychol Addict Behav. [Abstract] [Full-text]
  70. Psychopharmacological comparison of schizophrenia spectrum disorder with and without cannabis dependency.
    Prog Neuropsychopharmacol Biol Psychiatry, 35(1): 212-7. [Abstract] [Full-text]
  71. Overview and initial validation of two detailed, multidimensional, retrospective measures of substance use: The Lifetime Substance Use Recall (LSUR) and Longitudinal Substance Use Recall for 12 Weeks (LSUR-12) Instruments.
    J Psychiatr Res, 45(1): 83-91. [Abstract] [Full-text]
  72. A combined preclinical therapy of cannabinoids and temozolomide against glioma.
    Mol Cancer Ther, 10(1): 90-103. [Abstract] [Full-text]
  73. Alcohol, cannabis and amphetamine-type stimulants use among young Pacific Islanders.
    Drug Alcohol Rev, 30(1): 104-10. [Abstract] [Full-text]
  74. Recreational substance use among elite Australian athletes.
    Drug Alcohol Rev, 30(1): 63-8. [Abstract] [Full-text]
  75. Detecting psychological symptoms related to substance use among Indigenous Australians.
    Drug Alcohol Rev, 30(1): 33-9. [Abstract] [Full-text]
  76. Reported value of cannabis seizures in Australian newspapers: are they accurate?
    Drug Alcohol Rev, 30(1): 21-5. [Abstract] [Full-text]
  77. Prevalence and intensity of basic symptoms among cannabis users: an observational study.
    Am J Drug Alcohol Abuse. [Abstract] [Full-text]
  78. Race and Sexually Transmitted Diseases in Women With and Without Borderline Personality Disorder.
    J Womens Health (Larchmt). [Abstract] [Full-text]
  79. Changes in self-control problems and attention problems during middle school predict alcohol, tobacco, and marijuana use during high school.
    Psychol Addict Behav. [Abstract] [Full-text]
  80. Psychopharmacological comparison of schizophrenia spectrum disorder with and without cannabis dependency.
    Prog Neuropsychopharmacol Biol Psychiatry, 35(1): 212-7. [Abstract] [Full-text]
  81. Overview and initial validation of two detailed, multidimensional, retrospective measures of substance use: the Lifetime Substance Use Recall (LSUR) and Longitudinal Substance Use Recall for 12 Weeks (LSUR-12) Instruments.
    J Psychiatr Res, 45(1): 83-91. [Abstract] [Full-text]
  82. Race and Sexually Transmitted Diseases in Women With and Without Borderline Personality Disorder.
    J Womens Health (Larchmt). [Abstract] [Full-text]
  83. Changes in self-control problems and attention problems during middle school predict alcohol, tobacco, and marijuana use during high school.
    Psychol Addict Behav. [Abstract] [Full-text]
  84. Psychopharmacological comparison of schizophrenia spectrum disorder with and without cannabis dependency.
    Prog Neuropsychopharmacol Biol Psychiatry, 35(1): 212-7. [Abstract] [Full-text]
  85. Management of cannabis use during pregnancy: an assessment of healthcare professionals' practices.
    Pharmacoepidemiol Drug Saf. [Abstract] [Full-text]
  86. Management of cannabis use during pregnancy: an assessment of healthcare professionals' practices.
    Pharmacoepidemiol Drug Saf. [Abstract] [Full-text]
  87. Management of cannabis use during pregnancy: an assessment of healthcare professionals' practices.
    Pharmacoepidemiol Drug Saf. [Abstract] [Full-text]
  88. Interpersonal victimization, posttraumatic stress disorder, and change in adolescent substance use prevalence over a ten-year period.
    J Clin Child Adolesc Psychol, 40(1): 136-43. [Abstract] [Full-text]
  89. Frontal Assessment Battery (FAB) is a simple tool for detecting executive deficits in chronic cannabis users.
    J Clin Exp Neuropsychol. [Abstract] [Full-text]
  90. The role of sex steroid hormones, cytokines and the endocannabinoid system in female fertility.
    Hum Reprod Update. [Abstract] [Full-text]
  91. Separate and combined effects of the cannabinoid agonists nabilone and Δ(9)-THC in humans discriminating Δ(9)-THC.
    Drug Alcohol Depend. [Abstract] [Full-text]
  92. The putative cannabinoid receptor GPR55 promotes cancer cell proliferation.
    Oncogene, 30(2): 139-41. [Abstract] [Full-text]
  93. Interpersonal victimization, posttraumatic stress disorder, and change in adolescent substance use prevalence over a ten-year period.
    J Clin Child Adolesc Psychol, 40(1): 136-43. [Abstract] [Full-text]
  94. Frontal Assessment Battery (FAB) is a simple tool for detecting executive deficits in chronic cannabis users.
    J Clin Exp Neuropsychol. [Abstract] [Full-text]
  95. The role of sex steroid hormones, cytokines and the endocannabinoid system in female fertility.
    Hum Reprod Update. [Abstract] [Full-text]
  96. Separate and combined effects of the cannabinoid agonists nabilone and Δ(9)-THC in humans discriminating Δ(9)-THC.
    Drug Alcohol Depend. [Abstract] [Full-text]
  97. The putative cannabinoid receptor GPR55 promotes cancer cell proliferation.
    Oncogene, 30(2): 139-41. [Abstract] [Full-text]
  98. Nonmedical use of prescription drugs and HIV risk behavior in gay and bisexual men.
    Sex Transm Dis, 38(2): 105-10. [Abstract] [Full-text]
  99. Frontal Assessment Battery (FAB) is a simple tool for detecting executive deficits in chronic cannabis users.
    J Clin Exp Neuropsychol. [Abstract] [Full-text]
  100. The role of sex steroid hormones, cytokines and the endocannabinoid system in female fertility.
    Hum Reprod Update. [Abstract] [Full-text]
  101. Separate and combined effects of the cannabinoid agonists nabilone and Δ(9)-THC in humans discriminating Δ(9)-THC.
    Drug Alcohol Depend. [Abstract] [Full-text]
  102. The putative cannabinoid receptor GPR55 promotes cancer cell proliferation.
    Oncogene, 30(2): 139-41. [Abstract] [Full-text]
  103. Nonmedical use of prescription drugs and HIV risk behavior in gay and bisexual men.
    Sex Transm Dis, 38(2): 105-10. [Abstract] [Full-text]
  104. Nonmedical use of prescription drugs and HIV risk behavior in gay and bisexual men.
    Sex Transm Dis, 38(2): 105-10. [Abstract] [Full-text]
  105. Stimulation of the midkine/ALK axis renders glioma cells resistant to cannabinoid antitumoral action.
    Cell Death Differ. [Abstract] [Full-text]
  106. The use of anabolic androgenic steroids and polypharmacy: A review of the literature.
    Drug Alcohol Depend. [Abstract] [Full-text]
  107. Cannabis use and age at onset of psychosis: further evidence of interaction with COMT Val158Met polymorphism.
    Acta Psychiatr Scand. [Abstract] [Full-text]
  108. A Pilot Study of the Accuracy of Onsite Immunoassay Urinalysis of Illicit Drug Use in Seriously mentally ill outpatients.
    Am J Drug Alcohol Abuse. [Abstract] [Full-text]
  109. Stimulation of the midkine/ALK axis renders glioma cells resistant to cannabinoid antitumoral action.
    Cell Death Differ. [Abstract] [Full-text]
  110. The use of anabolic androgenic steroids and polypharmacy: A review of the literature.
    Drug Alcohol Depend. [Abstract] [Full-text]
  111. Cannabis use and age at onset of psychosis: further evidence of interaction with COMT Val158Met polymorphism.
    Acta Psychiatr Scand. [Abstract] [Full-text]
  112. A Pilot Study of the Accuracy of Onsite Immunoassay Urinalysis of Illicit Drug Use in Seriously mentally ill outpatients.
    Am J Drug Alcohol Abuse. [Abstract] [Full-text]
  113. Benzodiazepines and sedative-hypnotics in blood of drivers under the influence and their association with other common illegal drug use and national sales figures.
    Ther Drug Monit, 33(1): 64-71. [Abstract] [Full-text]
  114. Stimulation of the midkine/ALK axis renders glioma cells resistant to cannabinoid antitumoral action.
    Cell Death Differ. [Abstract] [Full-text]
  115. The use of anabolic androgenic steroids and polypharmacy: A review of the literature.
    Drug Alcohol Depend. [Abstract] [Full-text]
  116. Cannabis use and age at onset of psychosis: further evidence of interaction with COMT Val158Met polymorphism.
    Acta Psychiatr Scand. [Abstract] [Full-text]
  117. Benzodiazepines and sedative-hypnotics in blood of drivers under the influence and their association with other common illegal drug use and national sales figures.
    Ther Drug Monit, 33(1): 64-71. [Abstract] [Full-text]
  118. Benzodiazepines and sedative-hypnotics in blood of drivers under the influence and their association with other common illegal drug use and national sales figures.
    Ther Drug Monit, 33(1): 64-71. [Abstract] [Full-text]
  119. Association of secondhand smoke exposure with nicotine dependence among Black smokers.
    Addict Behav. [Abstract] [Full-text]
  120. Cannabidiol inhibits the hyperphagia induced by cannabinoid-1 or serotonin-1A receptor agonists.
    Pharmacol Biochem Behav. [Abstract] [Full-text]
  121. The relationship between impulsivity and craving in cocaine- and methamphetamine-dependent volunteers.
    Pharmacol Biochem Behav. [Abstract] [Full-text]
  122. Cannabis sativa and the Endogenous Cannabinoid System: Therapeutic Potential for Appetite Regulation.
    Phytother Res. [Abstract] [Full-text]
  123. Cannabidiol decreases body weight gain in rats: Involvement of CB2 receptors.
    Neurosci Lett. [Abstract] [Full-text]
  124. The relationship between impulsivity and craving in cocaine- and methamphetamine-dependent volunteers.
    Pharmacol Biochem Behav. [Abstract] [Full-text]
  125. The relationship between impulsivity and craving in cocaine- and methamphetamine-dependent volunteers.
    Pharmacol Biochem Behav. [Abstract] [Full-text]
  126. Correlates of at-risk/problem internet gambling in adolescents.
    J Am Acad Child Adolesc Psychiatry, 50(2): 150-159.e3. [Abstract] [Full-text]
  127. Correlates of at-risk/problem internet gambling in adolescents.
    J Am Acad Child Adolesc Psychiatry, 50(2): 150-159.e3. [Abstract] [Full-text]
  128. The potential for clinical use of cannabinoids in treatment of cardiovascular diseases.
    Cardiovasc Ther, 29(1): 17-22. [Abstract] [Full-text]
  129. Perinatal outcome of illicit substance use in pregnancy-comparative and contemporary socio-clinical profile in the UK.
    Eur J Pediatr, 170(2): 199-205. [Abstract] [Full-text]
  130. Correlates of at-risk/problem internet gambling in adolescents.
    J Am Acad Child Adolesc Psychiatry, 50(2): 150-159.e3. [Abstract] [Full-text]
  131. The potential for clinical use of cannabinoids in treatment of cardiovascular diseases.
    Cardiovasc Ther, 29(1): 17-22. [Abstract] [Full-text]
  132. Perinatal outcome of illicit substance use in pregnancy--comparative and contemporary socio-clinical profile in the UK.
    Eur J Pediatr, 170(2): 199-205. [Abstract] [Full-text]
  133. Correlates of at-risk/problem internet gambling in adolescents.
    J Am Acad Child Adolesc Psychiatry, 50(2): 150-159.e3. [Abstract] [Full-text]
  134. The potential for clinical use of cannabinoids in treatment of cardiovascular diseases.
    Cardiovasc Ther, 29(1): 17-22. [Abstract] [Full-text]
  135. Perinatal outcome of illicit substance use in pregnancy--comparative and contemporary socio-clinical profile in the UK.
    Eur J Pediatr, 170(2): 199-205. [Abstract] [Full-text]
  136. A Qualitative View of Drug Use Behaviors of Mexican Male Injection Drug Users Deported from the United States.
    J Urban Health. [Abstract] [Full-text]
  137. Associations of Social Phobia and General Anxiety with Alcohol and Drug Use in A Community Sample of Adolescents.
    Alcohol Alcohol. [Abstract] [Full-text]
  138. Health and well-being of young people who attend secondary school in Aotearoa, New Zealand: What has changed from 2001 to 2007?
    J Paediatr Child Health. [Abstract] [Full-text]
  139. The Cannabinoid Type-1 Receptor Carboxyl-Terminus, More Than Just a Tail.
    J Neurochem. [Abstract] [Full-text]
  140. A Qualitative View of Drug Use Behaviors of Mexican Male Injection Drug Users Deported from the United States.
    J Urban Health. [Abstract] [Full-text]
  141. Associations of Social Phobia and General Anxiety with Alcohol and Drug Use in A Community Sample of Adolescents.
    Alcohol Alcohol. [Abstract] [Full-text]
  142. Health and well-being of young people who attend secondary school in Aotearoa, New Zealand: What has changed from 2001 to 2007?
    J Paediatr Child Health. [Abstract] [Full-text]
  143. The Cannabinoid Type-1 Receptor Carboxyl-Terminus, More Than Just a Tail.
    J Neurochem. [Abstract] [Full-text]
  144. A Qualitative View of Drug Use Behaviors of Mexican Male Injection Drug Users Deported from the United States.
    J Urban Health. [Abstract] [Full-text]
  145. Associations of Social Phobia and General Anxiety with Alcohol and Drug Use in A Community Sample of Adolescents.
    Alcohol Alcohol. [Abstract] [Full-text]
  146. Health and well-being of young people who attend secondary school in Aotearoa, New Zealand: What has changed from 2001 to 2007?
    J Paediatr Child Health. [Abstract] [Full-text]
  147. Endocannabinoids in liver disease.
    Hepatology, 53(1): 346-55. [Abstract] [Full-text]
  148. Specificity of verbal learning impairment and recovery in a marijuana-dependent male: The effects of sustained marijuana abstinence.
    Cogn Neuropsychiatry. [Abstract] [Full-text]
  149. Psychometric properties of the Cannabis Abuse Screening Test (CAST) in a French sample of adolescents.
    Drug Alcohol Depend, 113(2): 229-35. [Abstract] [Full-text]
  150. Patterns of polydrug use in Great Britain: Findings from a national household population survey.
    Drug Alcohol Depend, 113(2): 222-8. [Abstract] [Full-text]
  151. Quantification and comparison of marijuana smoking practices: Blunts, joints, and pipes.
    Drug Alcohol Depend, 113(2): 249-51. [Abstract] [Full-text]
  152. Associations between abstinence in adolescence and economic and educational outcomes seven years later among high-risk youth.
    Drug Alcohol Depend, 113(2): 118-24. [Abstract] [Full-text]
  153. Specificity of verbal learning impairment and recovery in a marijuana-dependent male: The effects of sustained marijuana abstinence.
    Cogn Neuropsychiatry. [Abstract] [Full-text]
  154. Psychometric properties of the Cannabis Abuse Screening Test (CAST) in a French sample of adolescents.
    Drug Alcohol Depend, 113(2): 229-35. [Abstract] [Full-text]
  155. Patterns of polydrug use in Great Britain: findings from a national household population survey.
    Drug Alcohol Depend, 113(2): 222-8. [Abstract] [Full-text]
  156. Quantification and comparison of marijuana smoking practices: blunts, joints, and pipes.
    Drug Alcohol Depend, 113(2): 249-51. [Abstract] [Full-text]
  157. Associations between abstinence in adolescence and economic and educational outcomes seven years later among high-risk youth.
    Drug Alcohol Depend, 113(2): 118-24. [Abstract] [Full-text]
  158. Specificity of verbal learning impairment and recovery in a marijuana-dependent male: The effects of sustained marijuana abstinence.
    Cogn Neuropsychiatry. [Abstract] [Full-text]
  159. Psychotic symptoms in young adults exposed to childhood trauma-A 20year follow-up study.
    Schizophr Res. [Abstract] [Full-text]
  160. Motor and cognitive outcomes through three years of age in children exposed to prenatal methamphetamine.
    Neurotoxicol Teratol, 33(1): 176-84. [Abstract] [Full-text]
  161. The effects of prenatal marijuana exposure on delinquent behaviors are mediated by measures of neurocognitive functioning.
    Neurotoxicol Teratol, 33(1): 129-36. [Abstract] [Full-text]
  162. The effects of prenatal cocaine exposure and gender on inhibitory control and attention.
    Neurotoxicol Teratol, 33(1): 61-8. [Abstract] [Full-text]
  163. Estimated effects of in utero cocaine exposure on language development through early adolescence.
    Neurotoxicol Teratol, 33(1): 25-35. [Abstract] [Full-text]
  164. Cannabidiol inhibits the hyperphagia induced by cannabinoid-1 or serotonin-1A receptor agonists.
    Pharmacol Biochem Behav. [Abstract] [Full-text]
  165. Why do patients with psychosis use cannabis and are they ready to change their use?
    Int J Dev Neurosci. [Abstract] [Full-text]
  166. Brief integrative multiple behavior intervention effects and mediators for adolescents.
    J Behav Med, 34(1): 3-12. [Abstract] [Full-text]
  167. Parental alcohol dependence, socioeconomic disadvantage and alcohol and cannabis dependence among young adults in the community.
    Eur Psychiatry, 26(1): 13-7. [Abstract] [Full-text]
  168. Prenatal methamphetamine exposure and neonatal neurobehavioral outcome in the USA and New Zealand.
    Neurotoxicol Teratol, 33(1): 166-75. [Abstract] [Full-text]
  169. Adolescent initiation of licit and illicit substance use: Impact of intrauterine exposures and post-natal exposure to violence.
    Neurotoxicol Teratol, 33(1): 100-9. [Abstract] [Full-text]
  170. Mental disorders and delivery motorcycle drivers (motoboys): A dangerous association.
    Eur Psychiatry, 26(1): 23-7. [Abstract] [Full-text]
  171. Psychotic symptoms in young adults exposed to childhood trauma-A 20year follow-up study.
    Schizophr Res. [Abstract] [Full-text]
  172. Cannabidiol inhibits the hyperphagia induced by cannabinoid-1 or serotonin-1A receptor agonists.
    Pharmacol Biochem Behav. [Abstract] [Full-text]
  173. Brief integrative multiple behavior intervention effects and mediators for adolescents.
    J Behav Med, 34(1): 3-12. [Abstract] [Full-text]
  174. Psychotic symptoms in young adults exposed to childhood trauma-A 20year follow-up study.
    Schizophr Res. [Abstract] [Full-text]
  175. Brief integrative multiple behavior intervention effects and mediators for adolescents.
    J Behav Med, 34(1): 3-12. [Abstract] [Full-text]
  176. The Social Contagion Effect of Marijuana Use among Adolescents.
    PLoS One, 6(1): e16183. [Abstract] [Full-text]
  177. Effects on sleep and dopamine levels of microdialysis perfusion of cannabidiol into the lateral hypothalamus of rats.
    Life Sci. [Abstract] [Full-text]
  178. The histopathology of drugs of abuse.
    Histopathology. [Abstract] [Full-text]
  179. Cannabis use among military veterans after residential treatment for posttraumatic stress disorder.
    Psychol Addict Behav. [Abstract] [Full-text]
  180. Development of a decisional balance scale for young adult marijuana use.
    Psychol Addict Behav. [Abstract] [Full-text]
  181. Cannabidiol decreases body weight gain in rats: Involvement of CB2 receptors.
    Neurosci Lett, 490(1): 82-4. [Abstract] [Full-text]
  182. Screen time and risk behaviors in 10- to 16-year-old Canadian youth.
    Prev Med, 52(2): 99-103. [Abstract] [Full-text]
  183. The social contagion effect of marijuana use among adolescents.
    PLoS One, 6(1): e16183. [Abstract] [Full-text]
  184. The histopathology of drugs of abuse.
    Histopathology. [Abstract] [Full-text]
  185. Cannabis use among military veterans after residential treatment for posttraumatic stress disorder.
    Psychol Addict Behav. [Abstract] [Full-text]
  186. Development of a decisional balance scale for young adult marijuana use.
    Psychol Addict Behav. [Abstract] [Full-text]
  187. Cannabidiol decreases body weight gain in rats: involvement of CB2 receptors.
    Neurosci Lett, 490(1): 82-4. [Abstract] [Full-text]
  188. Screen time and risk behaviors in 10- to 16-year-old Canadian youth.
    Prev Med, 52(2): 99-103. [Abstract] [Full-text]
  189. The histopathology of drugs of abuse.
    Histopathology. [Abstract] [Full-text]
  190. Cannabis use among military veterans after residential treatment for posttraumatic stress disorder.
    Psychol Addict Behav. [Abstract] [Full-text]
  191. Development of a decisional balance scale for young adult marijuana use.
    Psychol Addict Behav. [Abstract] [Full-text]
  192. Cannabidiol decreases body weight gain in rats: involvement of CB2 receptors.
    Neurosci Lett, 490(1): 82-4. [Abstract] [Full-text]
  193. Screen time and risk behaviors in 10- to 16-year-old Canadian youth.
    Prev Med, 52(2): 99-103. [Abstract] [Full-text]
  194. Cannabidiol decreases body weight gain in rats: involvement of CB2 receptors.
    Neurosci Lett, 490(1): 82-4. [Abstract] [Full-text]
  195. Excessive cannabis use is associated with earlier age at onset in bipolar disorder.
    Eur Arch Psychiatry Clin Neurosci. [Abstract] [Full-text]
  196. Drug-induced psychosis: how to avoid star gazing in schizophrenia research by looking at more obvious sources of light.
    Front Behav Neurosci, 5: 1. [Abstract] [Full-text]
  197. Cannabis intoxication in three Green iguanas (Iguana iguana).
    J Small Anim Pract, 52(2): 113-6. [Abstract] [Full-text]
  198. Excessive cannabis use is associated with earlier age at onset in bipolar disorder.
    Eur Arch Psychiatry Clin Neurosci. [Abstract] [Full-text]
  199. Drug-induced psychosis: how to avoid star gazing in schizophrenia research by looking at more obvious sources of light.
    Front Behav Neurosci, 5: 1. [Abstract] [Full-text]
  200. Cannabis intoxication in three Green iguanas (Iguana iguana).
    J Small Anim Pract, 52(2): 113-6. [Abstract] [Full-text]
  201. Excessive cannabis use is associated with earlier age at onset in bipolar disorder.
    Eur Arch Psychiatry Clin Neurosci. [Abstract] [Full-text]
  202. Cannabis intoxication in three Green iguanas (Iguana iguana).
    J Small Anim Pract, 52(2): 113-6. [Abstract] [Full-text]
  203. Dimensions of Adolescent Psychopathology and Relationships to Suicide Risk Indicators.
    J Youth Adolesc. [Abstract] [Full-text]
  204. Acceptability of a clinician-assisted computerized psychological intervention for comorbid mental health and substance use problems: treatment adherence data from a randomized controlled trial.
    J Med Internet Res, 13(1): e11. [Abstract] [Full-text]
  205. Allergic hypersensitivity to cannabis in patients with allergy and illicit drug users.
    Allergol Immunopathol (Madr). [Abstract] [Full-text]
  206. MAKINGtheLINK: a school-based health promotion programme to increase help-seeking for cannabis and mental health issues among adolescents.
    Early Interv Psychiatry, 5(1): 81-8. [Abstract] [Full-text]
  207. The history and current state of drug abuse in Japan.
    Ann N Y Acad Sci, 1216(1): 62-72. [Abstract] [Full-text]
  208. The Effects of Drug-Prevention Messages on the Accessibility of Identity-Related Constructs.
    J Health Commun. [Abstract] [Full-text]
  209. Assessing Media Campaigns Linking Marijuana Non-Use with Autonomy and Aspirations: "Be Under Your Own Influence" and ONDCP's "Above the Influence"
    Prev Sci. [Abstract] [Full-text]
  210. Is There a Legitimate Role for the Therapeutic Use of Cannabinoids for Symptom Management in Chronic Kidney Disease?
    J Pain Symptom Manage. [Abstract] [Full-text]
  211. Impact of Cannabis Use on Male Sexual Health.
    J Sex Med. [Abstract] [Full-text]
  212. The safety of modafinil in combination with oral ∆9-tetrahydrocannabinol in humans.
    Pharmacol Biochem Behav, 98(1): 94-100. [Abstract] [Full-text]
  213. Dimensions of Adolescent Psychopathology and Relationships to Suicide Risk Indicators.
    J Youth Adolesc. [Abstract] [Full-text]
  214. Acceptability of a clinician-assisted computerized psychological intervention for comorbid mental health and substance use problems: treatment adherence data from a randomized controlled trial.
    J Med Internet Res, 13(1): e11. [Abstract] [Full-text]
  215. Allergic hypersensitivity to cannabis in patients with allergy and illicit drug users.
    Allergol Immunopathol (Madr). [Abstract] [Full-text]
  216. MAKINGtheLINK: a school-based health promotion programme to increase help-seeking for cannabis and mental health issues among adolescents.
    Early Interv Psychiatry, 5(1): 81-8. [Abstract] [Full-text]
  217. The Effects of Drug-Prevention Messages on the Accessibility of Identity-Related Constructs.
    J Health Commun. [Abstract] [Full-text]
  218. Is There a Legitimate Role for the Therapeutic Use of Cannabinoids for Symptom Management in Chronic Kidney Disease?
    J Pain Symptom Manage. [Abstract] [Full-text]
  219. Impact of Cannabis Use on Male Sexual Health.
    J Sex Med. [Abstract] [Full-text]
  220. Dimensions of Adolescent Psychopathology and Relationships to Suicide Risk Indicators.
    J Youth Adolesc. [Abstract] [Full-text]
  221. Acceptability of a clinician-assisted computerized psychological intervention for comorbid mental health and substance use problems: treatment adherence data from a randomized controlled trial.
    J Med Internet Res, 13(1): e11. [Abstract] [Full-text]
  222. Allergic hypersensitivity to cannabis in patients with allergy and illicit drug users.
    Allergol Immunopathol (Madr). [Abstract] [Full-text]
  223. MAKINGtheLINK: a school-based health promotion programme to increase help-seeking for cannabis and mental health issues among adolescents.
    Early Interv Psychiatry, 5(1): 81-8. [Abstract] [Full-text]
  224. The Effects of Drug-Prevention Messages on the Accessibility of Identity-Related Constructs.
    J Health Commun. [Abstract] [Full-text]
  225. Is There a Legitimate Role for the Therapeutic Use of Cannabinoids for Symptom Management in Chronic Kidney Disease?
    J Pain Symptom Manage. [Abstract] [Full-text]
  226. Impact of Cannabis Use on Male Sexual Health.
    J Sex Med. [Abstract] [Full-text]
  227. The safety of modafinil in combination with oral ∆9-tetrahydrocannabinol in humans.
    Pharmacol Biochem Behav, 98(1): 94-100. [Abstract] [Full-text]
  228. Inhibition of endocannabinoid catabolic enzymes elicits anxiolytic-like effects in the marble burying assay.
    Pharmacol Biochem Behav, 98(1): 21-7. [Abstract] [Full-text]
  229. The safety of modafinil in combination with oral ∆9-tetrahydrocannabinol in humans.
    Pharmacol Biochem Behav, 98(1): 94-100. [Abstract] [Full-text]
  230. Inhibition of endocannabinoid catabolic enzymes elicits anxiolytic-like effects in the marble burying assay.
    Pharmacol Biochem Behav, 98(1): 21-7. [Abstract] [Full-text]
  231. The safety of modafinil in combination with oral ∆9-tetrahydrocannabinol in humans.
    Pharmacol Biochem Behav, 98(1): 94-100. [Abstract] [Full-text]
  232. Inhibition of endocannabinoid catabolic enzymes elicits anxiolytic-like effects in the marble burying assay.
    Pharmacol Biochem Behav, 98(1): 21-7. [Abstract] [Full-text]
  233. Prevalence of illicit drug use among the Italian athlete population with special attention on drugs of abuse: A 10-year review.
    J Sports Sci. [Abstract] [Full-text]
  234. Differences in drug consumption, comorbidity and health service use of opioid addicts across six European urban regions (TREAT-project).
    Eur Psychiatry. [Abstract] [Full-text]
  235. Sex differences in smoking cessation outcomes of a tailored program for individuals with substance use disorders and mental illness.
    Addict Behav. [Abstract] [Full-text]
  236. Expectancies and self-efficacy mediate the effects of impulsivity on marijuana use outcomes: An application of the acquired preparedness model.
    Addict Behav, 36(4): 389-96. [Abstract] [Full-text]
  237. Drinking and driving among immigrant and US-born Hispanic young adults: Results from a longitudinal and nationally representative study.
    Addict Behav, 36(4): 381-8. [Abstract] [Full-text]
  238. A brief marijuana intervention for non-treatment-seeking young adult women.
    J Subst Abuse Treat, 40(2): 189-98. [Abstract] [Full-text]
  239. Prevalence of illicit drug use among the Italian athlete population with special attention on drugs of abuse: A 10-year review.
    J Sports Sci. [Abstract] [Full-text]
  240. Differences in drug consumption, comorbidity and health service use of opioid addicts across six European urban regions (TREAT-project).
    Eur Psychiatry. [Abstract] [Full-text]
  241. Sex differences in smoking cessation outcomes of a tailored program for individuals with substance use disorders and mental illness.
    Addict Behav. [Abstract] [Full-text]
  242. Differences in drug consumption, comorbidity and health service use of opioid addicts across six European urban regions (TREAT-project).
    Eur Psychiatry. [Abstract] [Full-text]
  243. A brief marijuana intervention for non-treatment-seeking young adult women.
    J Subst Abuse Treat, 40(2): 189-98. [Abstract] [Full-text]
  244. Δ9-tetrahydrocannabinol and its major metabolite Δ9-tetrahydrocannabinol-11-oic acid as 15-lipoxygenase inhibitors.
    J Pharm Sci, 100(3): 1206-11. [Abstract] [Full-text]
  245. Neonatal and maternal outcomes following maternal use of buprenorphine or methadone during pregnancy: findings of a retrospective audit.
    Women Birth, 24(1): 32-9. [Abstract] [Full-text]
  246. A brief marijuana intervention for non-treatment-seeking young adult women.
    J Subst Abuse Treat, 40(2): 189-98. [Abstract] [Full-text]
  247. Δ9-tetrahydrocannabinol and its major metabolite Δ9-tetrahydrocannabinol-11-oic acid as 15-lipoxygenase inhibitors.
    J Pharm Sci, 100(3): 1206-11. [Abstract] [Full-text]
  248. Neonatal and maternal outcomes following maternal use of buprenorphine or methadone during pregnancy: findings of a retrospective audit.
    Women Birth, 24(1): 32-9. [Abstract] [Full-text]
  249. Association of secondhand smoke exposure with nicotine dependence among Black smokers.
    Addict Behav, 36(4): 412-5. [Abstract] [Full-text]
  250. Expectancies and self-efficacy mediate the effects of impulsivity on marijuana use outcomes: an application of the acquired preparedness model.
    Addict Behav, 36(4): 389-96. [Abstract] [Full-text]
  251. Drinking and driving among immigrant and US-born Hispanic young adults: results from a longitudinal and nationally representative study.
    Addict Behav, 36(4): 381-8. [Abstract] [Full-text]
  252. A dual process account of adolescent and adult binge drinking.
    Addict Behav, 36(4): 341-6. [Abstract] [Full-text]
  253. Quantification of the influence of friends and antisocial behaviour in adolescent consumption of cannabis using the ZINB model and data mining.
    Addict Behav, 36(4): 368-74. [Abstract] [Full-text]
  254. Psychosocial correlates of adolescent marijuana use: variations by status of marijuana use.
    Addict Behav, 36(4): 404-7. [Abstract] [Full-text]
  255. A brief marijuana intervention for non-treatment-seeking young adult women.
    J Subst Abuse Treat, 40(2): 189-98. [Abstract] [Full-text]
  256. Δ9-tetrahydrocannabinol and its major metabolite Δ9-tetrahydrocannabinol-11-oic acid as 15-lipoxygenase inhibitors.
    J Pharm Sci, 100(3): 1206-11. [Abstract] [Full-text]
  257. Neonatal and maternal outcomes following maternal use of buprenorphine or methadone during pregnancy: findings of a retrospective audit.
    Women Birth, 24(1): 32-9. [Abstract] [Full-text]
  258. Association of secondhand smoke exposure with nicotine dependence among Black smokers.
    Addict Behav, 36(4): 412-5. [Abstract] [Full-text]
  259. Expectancies and self-efficacy mediate the effects of impulsivity on marijuana use outcomes: an application of the acquired preparedness model.
    Addict Behav, 36(4): 389-96. [Abstract] [Full-text]
  260. Drinking and driving among immigrant and US-born Hispanic young adults: results from a longitudinal and nationally representative study.
    Addict Behav, 36(4): 381-8. [Abstract] [Full-text]
  261. A dual process account of adolescent and adult binge drinking.
    Addict Behav, 36(4): 341-6. [Abstract] [Full-text]
  262. Quantification of the influence of friends and antisocial behaviour in adolescent consumption of cannabis using the ZINB model and data mining.
    Addict Behav, 36(4): 368-74. [Abstract] [Full-text]
  263. Psychosocial correlates of adolescent marijuana use: variations by status of marijuana use.
    Addict Behav, 36(4): 404-7. [Abstract] [Full-text]
  264. Acute treatment with cannabinoid receptor agonist WIN55212.2 improves prepulse inhibition in psychosocially stressed mice.
    Behav Brain Res, 218(2): 280-7. [Abstract] [Full-text]
  265. Association of secondhand smoke exposure with nicotine dependence among Black smokers.
    Addict Behav, 36(4): 412-5. [Abstract] [Full-text]
  266. Expectancies and self-efficacy mediate the effects of impulsivity on marijuana use outcomes: an application of the acquired preparedness model.
    Addict Behav, 36(4): 389-96. [Abstract] [Full-text]
  267. Drinking and driving among immigrant and US-born Hispanic young adults: results from a longitudinal and nationally representative study.
    Addict Behav, 36(4): 381-8. [Abstract] [Full-text]
  268. A dual process account of adolescent and adult binge drinking.
    Addict Behav, 36(4): 341-6. [Abstract] [Full-text]
  269. Quantification of the influence of friends and antisocial behaviour in adolescent consumption of cannabis using the ZINB model and data mining.
    Addict Behav, 36(4): 368-74. [Abstract] [Full-text]
  270. Psychosocial correlates of adolescent marijuana use: variations by status of marijuana use.
    Addict Behav, 36(4): 404-7. [Abstract] [Full-text]
  271. Acute treatment with cannabinoid receptor agonist WIN55212.2 improves prepulse inhibition in psychosocially stressed mice.
    Behav Brain Res, 218(2): 280-7. [Abstract] [Full-text]
  272. Acute treatment with cannabinoid receptor agonist WIN55212.2 improves prepulse inhibition in psychosocially stressed mice.
    Behav Brain Res, 218(2): 280-7. [Abstract] [Full-text]
Place a permanent text-link or advertisement here for just US$15.

© 2004-2011 Marijuana Research Today. All Rights Reserved.

Marijuana Research Today Archive:

Volume 1 (2004)
  Issue 1 (September)
  Issue 2 (October)
  Issue 3 (November)
  Issue 4 (December)

Volume 2 (2005)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 3 (2006)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 4 (2007)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 5 (2008)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 6 (2009)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 7 (2010)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 8 (2011)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)



Marijuana Books

Growing Marijuana Hydroponically

Growing Marijuana Hydroponically